Infectious Etiologies and Patient Outcomes in Pediatric Septic Shock
|
|
- Michael Elliott
- 6 years ago
- Views:
Transcription
1 Journal of the Pediatric Infectious Diseases Society ORIGINAL ARTICLE Infectious Etiologies and Patient Outcomes in Pediatric Septic Shock Stefanie G. Ames, 1 Jennifer K. Workman, 2 Jared A. Olson, 4 E. Kent Korgenski, 6 Susan Masotti, 5 Elizabeth D. Knackstedt, 3 Susan L. Bratton, 2 Gitte Y. Larsen 2 1 Department of Pediatrics, 2 Division of Critical Care, Department of Pediatrics, and 3 Division of Infectious Disease, Department of Pediatrics, University of Utah, 4 Department of Pharmacy, and 5 System Improvement, Primary Children s Hospital, and 6 Pediatric Clinical Program, Intermountain Healthcare, Salt Lake City, Utah Background. Septic shock remains an important cause of death and disability in children. Optimal care requires early recognition and treatment. Methods. We evaluated a retrospective cohort of children (age <19) treated in our emergency department (ED) for septic shock during to investigate the association between timing of antibiotic therapy and outcomes. The exposures were (1) receipt of empiric antibiotics in 1 hour and (2) receipt of appropriate antibiotics in 1 hour. The primary outcome was development of new or progressive multiple system organ dysfunction syndrome (NP-MODS). The secondary outcome was mortality. Results. Among 321 patients admitted to intensive care, 48% (n = 153) received empiric antibiotics in 1 hour. These patients were more ill at presentation with significantly greater median pediatric index of mortality 2 (PIM2) scores and were more likely to receive recommended resuscitation in the ED (61% vs 14%); however, rates of NP-MODS (9% vs 12%) and hospital mortality (7% vs 4%) were similar to those treated later.early, appropriate antibiotics were administered to 33% (n = 67) of patients with identified or suspected bacterial infection. These patients had significantly greater PIM2 scores but similar rates of NP-MODS (15% vs 15%) and hospital mortality (10% vs 6%) to those treated later. Conclusions. Critically ill children with septic shock treated in a children's hospital ED who received antibiotics in 1 hour were significantly more severely ill than those treated later, but they did not have increased risk of NP-MODS or death. Keywords. anti-bacterial agents; critical care; pediatrics; septic shock severe sepsis. Septic shock is an important cause of death and long-term morbidity in US children [1]. The prevalence of pediatric septic shock has increased, but prior to programs for early recognition and treatment, mortality had remained unchanged [2 4]. Delay in treatment of shock and subsequent development of acute multiorgan failure increases risk of death [4]. Early resuscitation of shock to mitigate or prevent progression of organ failure was demonstrated to decrease mortality in adults in 2001 [5]. Early recognition of shock followed by timely treatment of the underlying cause and rapid reversal of cardiovascular insufficiency using protocol-based care is now accepted as standard medical practice. These goals are the cornerstone of the Surviving Sepsis Campaign (SSC) [6]. An important aspect of early goal directed therapy is the rapid administration of antibiotics. The SSC endorses administering antibiotics within 1 hour of shock recognition [6]. However, rapid antibiotic therapy is a nuanced factor because not all patients with septic shock have bacterial infections, and among those with treatable bacterial infections, the initial coverage may be inadequate. Delaying treatment with appropriate antibiotics is associated with increased mortality in adults [7]. Our children's hospital emergency department (ED) has an ongoing quality improvement program for early recognition and treatment of pediatric septic shock [8]. This program has been in place since 2007, and adherence to recommended interventions including rapid antibiotic administration has increased over time [8]. In the present study, we evaluate whether administration of empiric and appropriate antibiotics in the ED within 1 hour from identification of shock is associated with decreased development of new or progressive multiple organ dysfunction syndrome (NP-MODS) compared with those treated later. We also describe infectious etiologies in children presenting to our ED with septic shock as well as the choice and timing of empiric antibiotic therapy. Received 27 August 2015; accepted 15 December Correspondence: J. K. Workman, MD, Division of Pediatric Critical Care, PO Box , Salt Lake City, UT (jennifer.workman@hsc.utah.edu). Journal of the Pediatric Infectious Diseases Society 2017;6(1):80 6 The Author Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please journals.permissions@oup.com. DOI: /jpids/piv108 METHODS Study Design and Setting We evaluated the relationship between timing of antibiotic administration for treatment of septic shock and outcomes of children requiring admission to the pediatric intensive care unit (PICU). We retrospectively identified patients presenting 80 JPIDS 2017:6 (March) Ames et al
2 to the ED with septic shock between 2008 and 2012, and we reviewed the hospital course and clinical outcomes. The study was conducted at Primary Children's Hospital (PCH), a tertiary care pediatric hospital with ED visits per year and 2000 PICU admissions per year. The University of Utah Institutional Review Board approved the study and waived requirement for informed consent. Participant Selection Criteria Initial patient selection was from the PCH Pediatric Septic Shock Project Database, which was established with initiation of the PCH ED Septic Shock Guidelines in Patient records were flagged for initial review and possible inclusion in this database if they met any of the following broad criteria: (1) triage in the ED to emergent status, (2) lactate drawn during ED course, (3) PICU admission within 12 hours of presentation to ED, (4) repeat visits to the ED within 48 hours of initial visit, and (5) having a rapid response called on a patient within 12 hours of admission from the ED to an inpatient ward for management of sepsis. After initial screening, patients were retained in this database if their condition met the American College of Critical Care Medicine (ACCM)/Pediatric Advanced Life Support (PALS) definition of septic shock: known or suspected infection accompanied by temperature abnormalities, vital sign abnormalities based on PALS vital sign parameters for age, and physical exam consistent with deficit in end-organ perfusion [9 11]. The ACCM/PALS definition was used because of its usefulness in bedside diagnosis and treatment in real time [12]. We included subjects for the present study if they were 18 years of age and were admitted from the PCH ED directly to the PICU between January 2008 and December Microbiology Definitions Patients with a primary bacterial infection had a culture taken on the day of hospitalization (urine, blood, cerebral spinal fluid [CSF], other sterile body fluid, or a wound culture) that grew pathogenic bacteria. Bacteria were classified as pathogenic if determined to be the cause of septic shock based on review of clinician documentation. A primary respiratory bacterial infection required the following: a respiratory sample from either an endobronchial brush specimen, a tracheal aspirate, or a bronchial alveolar lavage that met Centers for Disease Control and Prevention criteria for a respiratory infection, and presence of an infiltrate on chest imaging [12]. Patients with presumed primary bacterial infections were defined as those with clinical documentation indicating a likely bacterial infection with a full treatment course of antibiotics but no positive culture. These included community-acquired pneumonia, aspiration pneumonia, intestinal and intra-abdominal infections, and life-threatening skin and soft tissue infection. Intra-abdominal infections include perforated bowel from any cause including appendicitis or necrotizing enterocolitis. Patients were determined to have a primary viral infection if bacterial cultures were negative and a viral respiratory panel or viral polymerase chain reaction (PCR) study was positive. Patients without an infectious source identified were classified as no source identified. Exposures and Outcome The principle exposure was receipt of empiric antibiotics 1 hour after recognition of septic shock in the ED, compared with later administration among all patients admitted to the PICU. Time to antibiotics was determined by time from triage in the ED to initial administration of medication. We additionally compared receipt of appropriate antibiotics in 1 hour among those with infections for which antibiotic therapy is recommended. These patients may have required additional or changed antibiotic therapy from the initial, empiric choice. Antibiotics were considered appropriate if the bacteria isolated were susceptible to the regimen given. For presumed bacterial infections, the antibiotics were considered appropriate when the spectrum of activity of the regimen was at least as broad as that recommended by the Infectious Disease Society of America clinical guidelines for bacterial pneumonia, skin and soft tissue infections, and intra-abdominal infections [14 16]. The primary outcome was development of NP-MODS. Given the relatively low pediatric mortality rate, surrogate measures of disease severity are often used. Sepsis is associated with MODS, and NP-MODS has been used as a surrogate measure in this way [17 19]. New or progressive multiple system organ dysfunction syndrome was defined as the development of 2 or more organ dysfunctions during the hospitalization that were not present on the initial day of admission, or worsening of organ failures present on admission. Organ dysfunction present on hospital day 1 was presumed to be present on arrival. Assessment was based on cardiovascular, pulmonary, renal, neurologic, hematologic, and hepatic function, based on the patient's worst parameter during a specified time period (Supplementary Table 1) [18, 19]. Death was not part of NP-MODS assessment. We assessed NP-MODS on days 1, 2, 5, 8, 12, 16, and 18 (or until hospital discharge, whichever was sooner). Data were abstracted from the Intermountain Enterprise Data Warehouse and by manual chart review. The ED course and compliance with the SSC recommendations was recorded [6]. Additional outcome measures including mortality, PICU and hospital length of stay, and hospital resource utilization were captured. All data were stored within the University of Utah Division of Pediatric Critical Care Data Coordinating Center secure server. Statistical Analysis Standard descriptive statistics were used to summarize patient characteristics. Groups were compared by exposure, using χ 2 test for categorical variables and Wilcoxon rank-sum test for continuous variables. A binomial logistic regression was used to estimate the relationship between receipt of early antibiotics Infections in Pediatric Septic Shock JPIDS 2017:6 (March) 81
3 and odds of NP-MODS (primary outcome) as well as mortality (secondary outcome), adjusting for severity of illness with pediatric index of mortality 2 scores (PIM2). Findings were considered statistically significant if P value was <.05. The Bonferroni adjustment was used for restriction of significance when multiple pairwise comparisons were made between groups. All data were analyzed using SPSS (Chicago, Illinois) software, 19th version. RESULTS Three hundred twenty-one patients met study criteria, and select demographic and clinical features are presented in Table 1. Bacterial infections were identified in 154 (48%) patients with septic shock. Presumed bacterial and viral infections accounted for 51 (16%) and 50 (16%) patients, respectively. The remaining 66 (21%) patients had no source of infection identified. Table 1 reports patient groups by infectious etiology. Those without an infectious pathogen identified were significantly more likely to have a complex chronic condition [20] compared with all other groups. Those with documented bacterial infections had significantly longer median hospital length of stay than those with presumed bacterial, viral, or no infection identified. New or progressive multiple system organ dysfunction syndrome was significantly more common in those with documented bacterial infections compared with children without a source of infection identified and those with viral infections. The positive bacterial cultures were as follows: 72 blood, 25 urine, 12 CSF, 10 stool, and 8 sterile body fluid infections. The remaining infections were respiratory and soft tissue infections. A summary of the isolated organisms is in Supplementary Table 2. The most common bacterial species were streptococcal (n = 42), staphylococcal (n = 25), and Gram-negative species (n = 66), of which 19 patients had Escherichia coli infections. Among those with a viral infection, 47 had a respiratory illness with rhinovirus isolated in 36% (n = 17) and respiratory Table 1. Select Patient Demographic and Clinical Characteristics by Infection Type a Characteristic Bacterial Infection N = 154 Presumed Bacterial Infection N = 51 Viral Infection N = 50 No Infection Identified N = 66 P Value Compares All Groups Demographic Characteristics Age, months 65 (13 156) 106 (33 159) 23 (4 128) 81 (21 163).01 Race.45 White 109 (71) 35 (69) 30 (60) 49 (74) Hispanic 20 (13) 7 (14) 6 (12) 6 (9) Other 25 (16) 9 (18) 14 (28) 11 (17) Male 78 (51) 22 (43) 28 (55) 37 (56).49 Study years (50) 26 (51) 17 (34) 28 (42) (50) 25 (49) 33 (66) 38 (58) Clinical Characteristics Tracheostomy dependence 9 (6) 5 (10) 5 (10) 9 (14).29 CCC [18] 45 (29) 18 (35) 10 (20) 31 (47).01 Number of CCC 0 (0,1) 0 (0, 1) 0 (0, 0) 1 (0, 1).01 Antibiotics given in ED 148 (96) 50 (98) 50 (100) 59 (89).03 Received empiric antibiotics 77 (50) 18 (35) 18 (36) 40 (61).01 1 hour Minutes to initial antibiotics 60 (42, 100) 75 (37, 120) 74 (44, 101) 55 (32, 88).1 Appropriate antibiotics 1 hour 56 (37) 11 (23) Not applicable Not applicable.23 Minutes to appropriate 92 (50, 238) 100 (65, 192) Not applicable Not applicable.65 antibiotics PIM2 ED 1.6 (1.2, 4.0) 1.4 (1.0, 3.1) 1.3 (1.0, 3.8) 1.8 (1.2, 5.1).09 Mechanical ventilation during 61 (40) 16 (31) 9 (18) b 16 (24).02 admission Vasoactive medications during 58 (38) 17 (33) 6 (12) b 20 (30).01 admission Length of PICU stay, days 1.9 (0.9, 6.3) 1.7 (0.9, 3.9) 1.7 (0.7, 2.9) 1.7 (0.7, 4.0).34 Length of hospital stay, days 7.1 (4.0, 13.2) 4.9 (3.2, 10.7) 3.7 b (2.5, 6.2) 4.4 b (2.2, 9.9) <.01 Death 10 (7) 3 (6) 0 4 (6).34 Greatest organ dysfunction on 2 (1,2) 1 (0, 2) b 1 (0, 1) b 1 (1, 2) b <.01 any PICU day NP-MODS 25 (16) 5 (10) 1 (2) b 3 (5) b <.01 Abbreviations: CCC, complex chronic condition; ED, emergency department; IQR, interquartile range; MODS, multiple organ dysfunction syndrome; NP-MODS, new or progressive multiple organ dysfunction syndrome; PICU, pediatric intensive care unit; PIM2, pediatric index of mortality 2. a Data are presented as either n (%) or median (IQR). b Significantly different than bacterial infection, P <.008 for pairwise comparisons. 82 JPIDS 2017:6 (March) Ames et al
4 syncytial virus isolated in 21% (n = 10). Two patients had enterovirus meningitis, and 1 had cytomegalovirus viremia. There were 4 children with bacterial diarrhea for which antibiotic treatment is not recommended. Of the patients with a bacterial infection for which antibiotic treatment is indicated, 145 (72%) of the bacterial pathogens were sensitive to ceftriaxone, which is the empiric antibiotic therapy recommended in the PCH ED septic shock guideline. Table 2 compares demographic and clinical features of patients who received empiric antibiotics in 1 hour (N = 153) to those treated later (N = 168). Those treated in 1 hour were more likely to receive initial resuscitation compliant with the SSC guidelines (61% vs 14%). They also had significantly greater risk of mortality estimated by PIM2 score, but neither mortality (7% vs 4%) nor development of NP-MODS (9% vs 12%) differed significantly from those treated after 1 hour. This nonsignificant relationship was also found among the subset of the cohort for whom antibiotic treatment is indicated, with mortality rates 11% vs 6% (relative risk [RR], 1.65; 95% confidence interval [CI], ) and development of NP-MODS 15% vs 18% (RR, 0.81; 95% CI, ), among those treated in 1 hour vs after 1 hour, respectively. Table 3 compares patients with bacterial infections for which antibiotic treatment is indicated who received early appropriate antibiotics in 1 hour (N = 67) to those treated after 1 hour (N = 134). This excludes patients with viral infections and no source of infection identified as well as those with bacterial infections for which treatment is not recommended (n = 4). Those receiving appropriate antibiotics in 1 hour were also more likely to receive initial resuscitation compliant with the SSC guidelines (69% vs 17%). They also had significantly greater risk of mortality estimated by PIM2 score and higher rates of mechanical ventilation. However, when adjusting for severity of illness using PIM2, neither mortality (10% vs 6%) nor development of NP-MODS (15% vs 15%) differed significantly between groups. Figure 1a compares development of NP-MODS in the ICU by hours elapsed to empiric antibiotic treatment among all patients (including patients with viral infections and no source identified). Almost half (n = 153) of patients received empiric antibiotics within 1 hour, 118 (37%) between 1 and 2 hours, 26 (8%) between 2 and 3 hours, 10 (3%) between hours 3 and 4, and 14 (4%) in greater than 4 hours. In total, 93% of patients received antibiotics within 3 hours of presentation. When comparing hourly interval to empiric antibiotics, there were no significant differences in development of NP-MODS. Figure 1b compares development of NP-MODS by hours elapsed until appropriate antibiotic treatment among the subset of patients with infections for which treatment is recommended. Sixty-seven (33%) patients received appropriate antibiotics within 1 hour, 56 (28%) patients between 1 and 2 hours, 16 (8%) patients between 2 and 3 hours, 15 (7%) patients between hours 3 and 4, and 47 (23%) in greater than 4 hours. When comparing hourly interval to appropriate antibiotics, there were no significant differences in development of NP-MODS. DISCUSSION Almost two thirds of children with septic shock admitted to the PICU from the ED had a definite or presumed bacterial infection. Among all children, those receiving empiric antibiotics 1 hour were significantly more severely ill at presentation to the ED but did not differ with respect to NP-MODS or mortality Table 2. Comparison of Demographic and Clinical Features of Patients Who Received Empiric Antibiotics in 1 Hour or Longer a Variable Empiric Antibiotics 1 Hour N = 153 Empiric Antibiotics >1 Hour N = 168 P Value Age years 5.0 (1.3, 12.9) 6.1 (1.1, 13.1).79 Minutes to initial antibiotics 40 (22, 50) 95 (75, 138) <.001 Any CCC 54 (35) 50 (30).30 Infection Type.01 Bacterial 77 (50) 77 (46) Presumed bacterial 18 (20) 33 (12) Viral 18 (12) 32 (19) No infectious source identified 40 (26) 26 (16) ED care compliant with sepsis guidelines 94 (61) 23 (14) <.001 PIM2 in ED 1.9 (1.3, 4.7) 1.3 (1.0, 3.5).001 Mechanical ventilation 55 (36) 47 (28).13 Vasoactive medications 53 (35) 48 (29).24 PICU length of stay 2.1 (0.8, 6.1) 1.6 (0.9, 3.6).10 Hospital length of stay 6.9 (3.0, 12.4) 4.7 (3.0, 9.6).10 Death 10 (7) 7 (4).34 Greatest organ dysfunction on any PICU day 1 (1, 2) 1 (1, 2).04 NP-MODS 14 (9) 20 (12).42 Abbreviations: CCC, complex chronic condition; ED, emergency department; IQR, interquartile range; MODS, multiple organ dysfunction syndrome; NP-MODS, new or progressive multiple organ dysfunction syndrome; PICU, pediatric intensive care unit; PIM2, pediatric index of mortality 2. a Data are presented as either n (%) or median (IQR). Infections in Pediatric Septic Shock JPIDS 2017:6 (March) 83
5 Table 3. Comparison of Demographic and Clinical Features of Patients Who Received Appropriate Antibiotics in 1 Hour or Longer a,b Variable Appropriate Antibiotics 1 Hour N = 67 Appropriate Antibiotics >1 Hour N = 134 P Value Age years 4.7 (1, 13.1) 6.3 (1.4, 13.4).38 Minutes to appropriate antibiotics 43 (26, 53) 153 (95, 329) <.01 Any CCC [12] 25 (37) 36 (27).13 Infection Type.08 Bacterial 56 (84) 95 (71) Presumed bacterial 11 (16) 37 (28) ED care compliant with sepsis guidelines 46 (69) 23 (17) <.001 PIM2 in ED 2.2 (1.4, 5.0) 1.4 (1.0, 2.7) <.001 PIM2 in PICU 1.4 (1.1, 5.7) 1.2 (1.0, 3.4) <.03 Mechanical ventilation 34 (52) 41 (31).005 Vasoactive medications 26 (39) 48 (36).68 ICU length of stay 2.5 (0.9, 7.6) 1.6 (0.9, 4.0).12 Hospital length of stay 8.9 (3.8, 14.2) 6.0 (3.7, 11.3).13 Death 7 (10) 6 (6).27 c Greatest organ dysfunction on any PICU day 2 (1, 3) 1 (1,2).005 NP-MODS 10 (15) 20 (15).89 c Abbreviations: CCC, complex chronic condition; ED, emergency department; ICU, intensive care unit; IQR, interquartile range; MODS, multiple organ dysfunction syndrome; NP-MODS, new or progressive multiple organ dysfunction syndrome; PICU, pediatric ICU; PIM2, pediatric index of mortality 2. a Data are presented as either n (%) or median (IQR). b Infections for which antibiotics are not recommended such as shigellosis are excluded n = 4. c Adjusted for PIM2 in ED. compared with those treated later. Among those with an infection treatable by antibiotics, children receiving appropriate antibiotics in 1 hour were also significantly more severely ill at presentation to the ED but did not have greater rates of NP-MODS or mortality compared with those treated later. Patients with bacterial infections had greater illness severity at presentation, were more likely to receive antibiotics in 1 hour and resuscitation in compliance with the SSC guidelines, and had significantly greater NP-MODS compared with children with viral infections or no infectious source identified. They also had significantly longer lengths of hospital stay. This is likely related to the pathophysiology of bacterial infections with greater activation of an inflammatory response [21, 22]. This is also consistent with other studies showing culture-positive bacterial infections associated with increased morbidity [23]. Among those with bacterial infections as the etiology of septic shock, the majority (72%) of isolates were sensitive to empiric therapy. This is similar to a report by Weiss et al [24] who showed that the majority (78%) of pediatric septic shock patients treated in a single children's hospital also received appropriate initial antibiotic therapy. We hypothesized that rapid administration ( 1 hour) of empiric antibiotics would be associated with decreased NP-MODS. We were surprised to find that although children treated in 1 hour presented more severely ill, they were more likely to receive SSC compliant care and had similar risk of NP-MODS and death compared with those treated later. Failure to demonstrate a benefit from timely empiric antibiotics may be due to increased error in measurement of patients likely to benefit from the exposure because only 62% had an infection for which antibiotics would be expected to improve the child's status. We also tested whether rapid appropriate antibiotic administration was associated with decreased risk of NP-MODS. Again, we found that children treated in 1 hour were more severely ill at presentation to the ED compared with those with delayed antibiotics, but there were no statistical differences in development of NP-MODS or mortality by time of antibiotic administration or type of infection (presumed or culture positive bacterial infections). Our findings differ from the majority of reports involving adult patients, showing delay to appropriate antibiotic administration and increased mortality [23, 25 27]. The recent study by Weiss et al [24] of children with septic shock suggested improved mortality and patient outcomes if appropriate antibiotic therapy was delivered within 3 hours of shock recognition. We did not find a similar mortality benefit. Our study has important differences compared with the report by Weiss et al [24]. The majority of our patients received antibiotics in 3 hours (93% vs 60%), and receipt of appropriate antibiotics in 1 hour was almost 3 times greater in our patients (33% vs 12%) [11]. Although both cohorts had similar rates of comorbid conditions and similar rates and infection types, the overall mortality (5% vs 12%, P =.08), support with mechanical ventilation (32% vs 62%, P <.001), receipt of vasoactive medications (31% vs 74%, P <.001), and ICU length of stay (2 vs 9 median days), were all greater in the previous report. However, we included only patients directly admitted to the PICU from the ED, used a slightly different definition of septic shock (ACCM/PALS [9] vs Goldstein et al [10]), and our patients had lower risk of mortality measured by PIM2 scores on presentation to the ICU after treatment in the ED. Thus, our patients 84 JPIDS 2017:6 (March) Ames et al
6 needed to identify the ideal time goal for early appropriate antibiotic therapy that impacts pediatric patient outcomes. CONCLUSIONS More than half of children presenting to the ED with septic shock requiring intensive care had a definite or presumed bacterial infection, and the recommended empiric antibiotic treatment at our hospital was appropriate in 72% of cases. Those treated with appropriate antibiotics in 1 hour were more ill when presenting to the ED with greater PIM2 scores, but they were also more likely to receive rapid resuscitation compliant with SSC guidelines. Despite increased illness severity on presentation, patients treated in 1 hour did not have an increased disease progression as quantified by NP-MODS or death. Because the natural history of untreated septic shock is development of multiple organ failure and death, our findings support the premise that early recognition and treatment of shock, including administration of timely, appropriate antibiotics, remains pivotal. Supplementary Data Supplementary materials are available at Journal of the Pediatric Infectious Diseases Society online. Figure 1. (a) Empiric antibiotic timing and development of new or progressive multiple organ dysfunction syndrome (NP-MODS). Patients who developed NP-MODS versus time from emergency department arrival to empiric antibiotics in hourly increments among all patients. The percentage of patients who developed NP-MODS (lighter portion) within each hour are reflected numerically above each bar. (b) Appropriate antibiotic timing and development of new or progressive multiple organ dysfunction syndrome (NP-MODS). Patients who developed NP-MODS versus time from emergency department arrival to appropriate antibiotics in hourly increments among patients with an infection for which antibiotics are recommended. This cohort is a subset of the study cohort and appropriate antibiotic administration may have required additional or changed drug from that empirically administered. The percentage of patients who developed NP-MODS (lighter portion) within each hour are reflected numerically above each bar. may have been less severely ill at recognition of shock, but they also likely benefitted from more rapid treatment, as evidenced by lack of disease progression toward NP-MODS and death. More importantly, because the majority of our patients received antibiotics in <3 hours, we had inadequate power to determine a difference at the 3-hour cutoff. Our study has several limitations. First, as a retrospective study evaluating appropriate antibiotic choices, we recognize that it is not always possible to predict the pathogen and appropriate antibiotic choice in real time. Second, because this is a single-center study, results may not be generalizable to other care settings. Third, there is a link between early receipt of antibiotics and the delivery of care consistent with the SSC guidelines, suggesting that clinical assessment of illness severity drives the intensity of care and is likely linked to subsequent development of NP-MODS and mortality. Larger, multicenter studies are Notes Acknowledgments. We thank Dr. Roni Lane (Department of Pediatrics, University of Utah) for outstanding leadership of the Primary Children's Sepsis Work group and careful review of this manuscript. We also thank Tanya Stout (Primary Children's Hospital, Department of Systems Improvement) for contributions to the septic shock database used in this study. Disclaimer. S. G. A. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Financial support. This work was supported in part by the Primary Children's Foundation Clinical Excellence Grants Program, which provided support for data collection and management. Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. References 1. Watson RS, Carcillo JA, Linde-Zwirble WT et al. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167: Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS. Trends in the epidemiology of pediatric severe sepsis. Pediatr Crit Care Med 2013; 14: Balamuth F, Weiss SL, Neuman MI et al. Pediatric severe sepsis in U.S. children's hospitals. Pediatr Crit Care Med 2014; 15: Kutko MC, Calarco MP, Flaherty MB et al. Mortality rates in pediatric septic shock with and without multiple organ system failure. Pediatr Crit Care Med 2003; 4: Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: Crit Care Med 2013; 41: Kumar A, Ellis P, Arabi Y et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136: Larsen GY, Mecham N, Greenberg R. An emergency department septic shock protocol and care guideline for children initiated at triage. Pediatrics 2011; 127:e Infections in Pediatric Septic Shock JPIDS 2017:6 (March) 85
7 9. Zaritsky AL, Nadkarni V, Hickey RW et al American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric basic life support. Pediatrics 2006; 117:e Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6: Brierley J, Carcillo JA, Choong K et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009; 37: Kuch BA, Carcillo JA, Han YY, Orr RA. Definitions of pediatric septic shock. Pediatr Crit Care Med 2005; 6: Centers for Disease Control and Prevention. CDC/NHSN Surveillance Definitions for Specific Types of Infections Website. Available at: PDFs/pscManual/17pscNosInfDef_current.pdf. Accessed December 1, Solomkin JS, Mazuski JE, Bradley JS et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: Bradley JS, Byington CL, Shah SS et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 2011; 53:e Stevens DL, Bisno AL, Chambers HF et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59:e Proulx F, Fayon M, Farrell C et al. Epidemiology of sepsis and multiple organ dysfunction syndrome in children. Chest 1996; 109: Doughty L, Carcillo J, Kaplan S et al. The compensatory anti-inflammatory cytokine interleukin 10 response in pediatric sepsis-induced multiple organ failure. Chest 1998; 113: Lacroix J, Hébert PC, Hutchison JS et al. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, Pediatrics 2000; 106: Lisboa T, Seligman R, Diaz E et al. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med 2008; 36: Deis JN, Creech CB, Estrada CM, Abramo TJ. Procalcitonin as a marker of severe bacterial infection in children in the emergency department. Pediatr Emerg Care 2010; 26: Gaieski DF, Mikkelsen ME, Band RA et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 38: Weiss SL, Fitzgerald JC, Balamuth F et al. Delayed antimicrobial therapy increases mortality and organ dysfunction duration in pediatric sepsis. Crit Care Med 2014; 42: Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: Paul M, Shani V, Muchtar E et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010; 54: Varula M, Karisson S, Parvianinen I et al. Community-acquired septic shock: early management and outcome in a nationwide study in Finland. Acta Anaesthesiol Scand 2007; 51: Ferrer R, Martin-Loeches I, Phillips G et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med 2014; 42: JPIDS 2017:6 (March) Ames et al
Adherence to PALS Sepsis Guidelines and Hospital Length of Stay
ARTICLE Adherence to PALS Sepsis Guidelines and Hospital Length of Stay AUTHORS: Raina Paul, MD, a Mark I. Neuman, MD, MPH, a Michael C. Monuteaux, ScD, a and Elliot Melendez, MD a,b a Division of Emergency
More informationBC Sepsis Network Emergency Department Sepsis Guidelines
The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to
More information3/14/2017. Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care. Objectives. Developmental Response to Sepsis
Pediatric Sepsis: From Goal Directed Therapy to Protocolized Care March 20, 2017 Reid WD Farris, MS MD Objectives Review the evolution & current state of the pediatric septic shock treatment guidelines
More informationImpact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department
Clin Exp Emerg Med 2014;1(1):35-40 http://dx.doi.org/10.15441/ceem.14.012 Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department
More informationNo conflicts of interest to disclose
No conflicts of interest to disclose Introduction Epidemiology Surviving sepsis guidelines 2012 Updates Resuscitation protocols Map Goals Transfusion Sepsis-3 Bundle Management Questions Sepsis is a systemic,
More informationObjectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy
Objectives Management of Septic Shock Review of the Evidence and Implementation of Pediatric Guidelines at Christus Santa Rosa Manish Desai, M.D. PL 5 2 nd year Pediatric Critical Care Fellow Review of
More informationSenior Project Proposal Abby Conn October 23, 2018
Senior Project Proposal Abby Conn October 23, 2018 I. Title of Project: Designing an Early Warning System for Pediatric Sepsis Detection at Northern Arizona Healthcare (NAH) II. Statement of Purpose: Sepsis
More informationApproach to Severe Sepsis. Jan Hau Lee, MBBS, MRCPCH. MCI Children s Intensive Care Unit KK Women s and Children's Hospital, Singapore
Approach to Severe Sepsis Jan Hau Lee, MBBS, MRCPCH. MCI Children s Intensive Care Unit KK Women s and Children's Hospital, Singapore 1 2 No conflict of interest Overview Epidemiology of Pediatric Severe
More informationUnderstand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the
Understand the scope of sepsis morbidity and mortality Identify risk factors that predispose a patient to development of sepsis Define and know the differences between sepsis, severe sepsis and septic
More informationPediatric Sepsis Treatment:
Disclosures Pediatric Sepsis Treatment: (treat) Early & (reevaluate) Often None June 11, 2018 Leslie Dervan, MD MS Pacific Northwest Sepsis Conference 1 Agenda Sepsis: pathophysiology at-a-glance Pediatric
More informationAndrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015
The TIMES Project: (Time to Initiation of Antibiotic Therapy in Medical Patients Presenting to the Emergency Department with Sepsis) - Preliminary Findings Andrea Blotsky MDCM FRCPC General Internal Medicine,
More informationSupplementary Online Content
Supplementary Online Content Lee JS, Nsa W, Hausmann LRM, et al. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med. Published online September
More informationStaging Sepsis for the Emergency Department: Physician
Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected
More informationOHSU. Update in Sepsis
Update in Sepsis Jonathan Pak, MD June 1, 2017 Structure of Talk 1. Sepsis-3: The latest definition 2. Clinical Management - Is EGDT dead? - Surviving Sepsis Campaign Guidelines 3. A novel therapy: Vitamin
More informationSepsis: What Is It Really?
Sepsis: What Is It Really? Steven D. Burdette, MD, FIDSA, FACP Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship for Premier Health and Miami
More informationDisclosures No conflicts of interest to disclose
Disclosures No conflicts of interest to disclose Sepsis: Improving Early Recognition Patricia Conlon, APRN, CNS, CNP & Kelly Fjerstad, MSN, MBA/HCM, RN, NE-BC Objectives Define sepsis and the scope of
More informationISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis
Appendix with supplementary material. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Supplementary Tables Table S1. Definitions
More informationUpdates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign
Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign Dr. Joseph K Erbe, DO Medical Director Hospitalist Division of Medicine Objectives 1. Review the
More informationComparison of a novel rapid fluid delivery device to traditional methods
1 Comparison of a novel rapid fluid delivery device to traditional methods Galen Robertson MS 1, Andrew Lane MS 1, Mark Piehl MD MPH 1,4, Travis Whitfill MPH 1,2, Hillary Spangler MD 3 1 410 Medical, Inc.;
More informationFluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS
Fluid Resuscitation and Monitoring in Sepsis Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS Learning Objectives Compare and contrast fluid resuscitation strategies in septic shock Discuss available
More informationSEPSIS & SEPTIC SHOCK
SEPSIS & SEPTIC SHOCK DISCLOSURE Relevant relationships with commercial entities none Potential for conflicts of interest within this presentation none Steps taken to review and mitigate potential bias
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients
More informationCommunity Acquired Pneumonia
April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of
More informationSepsis is an infection-initiated clinical syndrome that can
Feature Articles Functional Outcomes in Pediatric Severe Sepsis: Further Analysis of the Researching Severe Sepsis and Organ Dysfunction in Children: A Global Perspective Trial* Reid W. D. Farris, MD 1
More informationDisclosures. Objectives. Procalcitonin: Pearls and Pitfalls in Daily Practice
Procalcitonin: Pearls and Pitfalls in Daily Practice Sarah K Harrison, PharmD, BCCCP Clinical Pearl Disclosures The author of this presentation has no disclosures concerning possible financial or personal
More informationUpdates in Emergency Department Management of Sepsis
Resident Journal Review Updates in Emergency Department Management of Sepsis Authors: Eli Brown, MD; Allison Regan, MD; Kaycie Corburn, MD; Jacqueline Shibata, MD Edited by: Jay Khadpe, MD FAAEM; Michael
More informationSepsis 3.0: The Impact on Quality Improvement Programs
Sepsis 3.0: The Impact on Quality Improvement Programs Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care Warren Alpert Medical School of Brown University
More informationCurrent State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018
Current State of Pediatric Sepsis Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018 Objectives Review the history of pediatric sepsis Review the current definition of pediatric sepsis Review triage
More information5/1/2015 SEPSIS SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 INFECTION CAN BE CONFIRMED BY:
SURVIVING SEPSIS CAMPAIGN HOW TO APPROACH THE POSSIBLE SEPTIC CHILD 2015 Omer Nasiroglu MD Baptist Children s Hospital Pediatric Emergency Department SEPSIS IS A SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care
More informationIs nosocomial infection the major cause of death in sepsis?
Is nosocomial infection the major cause of death in sepsis? Warren L. Lee, MD PhD, FRCPC Department of Medicine University of Toronto There are no specific therapies for sepsis the graveyard for pharmaceutical
More informationKey Points. Angus DC: Crit Care Med 29:1303, 2001
Sepsis Key Points Sepsis is the combination of a known or suspected infection and an accompanying systemic inflammatory response (SIRS) Severe sepsis is sepsis with acute dysfunction of one or more organ
More informationBeyond the Reflex Arc: An Evidence-Based Discussion of the Management of Febrile Infants
Beyond the Reflex Arc: An Evidence-Based Discussion of the Management of Febrile Infants Cole Condra, MD MSc Division of Emergency Medical Services Children s Mercy Hospital October 1, 2011 Disclosure
More informationSeptic Shock. Rontgene M. Solante, MD, FPCP,FPSMID
Septic Shock Rontgene M. Solante, MD, FPCP,FPSMID Learning Objectives Identify situations wherein high or low BP are hemodynamically significant Recognize complications arising from BP emergencies Manage
More informationThe Role of POCT in Management of Infectious Disease in the Critical Care Setting
The Role of POCT in Management of Infectious Disease in the Critical Care Setting Nathan A Ledeboer Associate Professor of Pathology Medical College of Wisconsin Medical Director, Microbiology and Molecular
More informationWhat the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health
What the ED clinician needs to know about SEPSIS - 3 Anna Morgan Consultant EM Barts Health Aims: (1) To review the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) (2)
More informationProspective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital
Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Final Results Nathan Beahm, BSP, PharmD(student) September 10, 2016 Objectives Review background information
More informationNYSDOH Sepsis Q&A Session from February 2018 Data Abstraction Meetings Table of Content
NYSDOH Sepsis Q&A Session from February 2018 Data Abstraction Meetings Table of Content Adherence variables Q: within 3 hours of the start datetime. How can we document that monotherapy was started before
More informationSupplementary Online Content
Supplementary Online Content Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova N. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. doi:10.1001/jama.2017.4287
More informationCELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK: CISS Phase I Trial
CELLULAR IMMUNOTHERAPY FOR SEPTIC SHOCK: CISS Phase I Trial Lauralyn McIntyre, MD, FRCPC, MHSc Associate Professor, University of Ottawa Senior Scientist, Ottawa Hospital Research Institute CCCF MEETING,
More informationSEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.
SEPSIS: IT ALL BEGINS WITH INFECTION Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft. Worth 1 2 3 OBJECTIVES Review the new Sepsis 3 definitions of sepsis
More informationEarly Goal-Directed Therapy
Early Goal-Directed Therapy Where do we stand? Jean-Daniel Chiche, MD PhD MICU & Dept of Host-Pathogen Interaction Hôpital Cochin & Institut Cochin, Paris-F Resuscitation targets in septic shock 1 The
More informationChapter 5: Sepsis Stephen Lo
Chapter 5: Sepsis Stephen Lo Introduction Sepsis and its consequence are the bread and butter of intensive care medicine and management of it is time critical. This chapter will discuss the definitions,
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationJAMA. 2016;315(8): doi: /jama
JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287 SEPSIS 3 life-threatening organ dysfunction caused by a dysregulated host response to infection organ dysfunction: an increase in the SOFA
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationA BRIEF HISTORY OF SEPSIS. Euan Mackay
A BRIEF HISTORY OF SEPSIS Euan Mackay Aims History of sepsis definition Validity of new definition Hippocrates 4 th century BC Hippocrates introduced the term "σήψις the process of decay or decomposition
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationSUCCESS IN SEPSIS MORTALITY REDUCTION. Maryanne Whitney RN MSN CNS Improvement Advisor, Cynosure Health HRET HEN AK Webinar
SUCCESS IN SEPSIS MORTALITY REDUCTION Maryanne Whitney RN MSN CNS Improvement Advisor, Cynosure Health HRET HEN AK Webinar Got Sepsis? Now What?- Alerts & Bundles Maryanne Whitney RN, MS, CNS Improvement
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set
More informationSepsis Awareness and Education
Sepsis Awareness and Education Meets the updated New York State Department of Health (NYSDOH) requirements for Infection Control and Barrier Precautions coursework Element VII: Sepsis Awareness and Education
More informationPediatric Emergency Preparedness Training Seminar: NY State Sepsis Initiative Update May 24 th, 2017
Pediatric Emergency Preparedness Training Seminar: NY State Sepsis Initiative Update May 24 th, 2017 Marcus Friedrich, MD, MBA, FACP Medical Director Office of Quality and Patient Safety NYSDOH Marcus.Friedrich@health.ny.gov
More informationEarly Recognition and Timely Management of Sepsis Amid Changes in Definitions
Early Recognition and Timely Management of Sepsis Amid Changes in Definitions Tze Shien Lo, MD, FACP Chief, Infectious Disease Service Fargo VA Medical Center Professor of Medicine UND School of Medicine
More informationFaculty Disclosure. Stephen I. Pelton, MD. Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest.
Faculty Disclosure Stephen I. Pelton, MD Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest. Advances in the management of fever in infants 0 to 3 and
More informationIn-Hospital Quality-of-Care Measures for Pediatric Sepsis Syndrome
In-Hospital Quality-of-Care Measures for Pediatric Sepsis Syndrome Folafoluwa O. Odetola, MD, MPH, Gary Freed, MD, MPH, Caroline Shevrin, MS, Brian Madden, MS, Julie McCormick, MA, Kevin Dombkowski, DrPh
More informationSepsis. Reliability- can we achieve Dr Ron Daniels
Sepsis. Reliability- can we achieve it? @SepsisUK Dr Ron Daniels Chief Executive, Global Sepsis Alliance Fellow: NHS Improvement Faculty Chief Executive: United Kingdom Sepsis Trust & Chair, UK SSC RRAILS
More informationPediatric Shock. National Pediatric Nighttime Curriculum Written by Julia M. Gabhart, M.D. Lucile Packard Children s Hospital at Stanford
Pediatric Shock National Pediatric Nighttime Curriculum Written by Julia M. Gabhart, M.D. Lucile Packard Children s Hospital at Stanford Pre-Topic Questions 1. Why is it important to identify the stage
More informationEarly-goal-directed therapy and protocolised treatment in septic shock
CAT reviews Early-goal-directed therapy and protocolised treatment in septic shock Journal of the Intensive Care Society 2015, Vol. 16(2) 164 168! The Intensive Care Society 2014 Reprints and permissions:
More informationDisclosures. Background. Definitions. Why Worry about these Infants? Goals. Bacterial infection in the neonate and young infant: a review
Disclosures Bacterial infection in the neonate and young infant: a review Russell J. McCulloh, MD Med-Peds Infectious Diseases August 8, 2017 I have no financial interests to disclose Funding: Eva and
More informationSepsis clinical evolution: Understand essential challenges to developing effective queries
Understand essential challenges to developing effective queries ADVICE FROM THE ACDIS REGULATORY COMMITTEE Summary: This paper provides a timeline of the various sepsis definitions and their implications
More informationNothing to disclose 9/25/2017
Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Nothing to disclose 1 Explain
More information9/25/2017. Nothing to disclose
Nothing to disclose Jessie O Neal, PharmD, BCCCP Critical Care Clinical Pharmacist University of New Mexico Hospital New Mexico Society of Health-System Pharmacists 2017 Balloon Fiesta Symposium Explain
More informationLate diagnosis of influenza in adult patients during a seasonal outbreak
ORIGINAL ARTICLE Korean J Intern Med 2018;33:391-396 Late diagnosis of influenza in adult patients during a seasonal outbreak Seong-Ho Choi 1, Jin-Won Chung 1, Tark Kim 2, Ki-Ho Park 3, Mi Suk Lee 3, and
More informationSEP-1 CHALLENGING CASES WITH DR. TOWNSEND
UW MEDICINE PATIENTS ARE FIRST SEP-1 CHALLENGING CASES WITH DR. TOWNSEND AMADAE AREVALO RN, MSN, CCRN KATIE MEHRING RN, BSN, CCDS AMANDA SIGALA, RN, BSN, MPH, CPHQ JUNE 12, 2018 OBJECTIVES 1. Summarize
More informationInitial Resuscitation of Sepsis & Septic Shock
Initial Resuscitation of Sepsis & Septic Shock Dr. Fatema Ahmed MD (Critical Care Medicine) FCPS (Medicine) Associate professor Dept. of Critical Care Medicine BIRDEM General Hospital Is Sepsis a known
More informationImmunomodulation and Sepsis in Oncological Patients. Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC
Immunomodulation and Sepsis in Oncological Patients Imad Haddad, M.D. Medical Director, PICU Banner Children s Hospital at BDMC 1 Objectives Immune dys-regulation in oncological septic patients Implementation
More informationPrehospital recognition of sepsis Christopher W. Seymour, MD MSc
Prehospital recognition of sepsis Christopher W. Seymour, MD MSc The CRISMA Center Assistant Professor of Critical Care Medicine & Emergency Medicine University of Pittsburgh School of Medicine Disclosures
More informationAdvanced Pediatric Emergency Medicine Assembly
(+)Joan Shook, MD, FACEP Professor of Pediatrics, Baylor College of Medicine; Chief Safety Officer and Chief Clinical Information Officer, Texas Children's Hospital Advanced Pediatric Emergency Medicine
More informationSepsis: Identification and Management in an Acute Care Setting
Sepsis: Identification and Management in an Acute Care Setting Dr. Barbara M. Mills DNP Director Rapid Response Team/ Code Resuscitation Stony Brook University Medical Center SEPSIS LECTURE NPA 2018 OBJECTIVES
More informationFever in neonates (age 0 to 28 days)
Fever in neonates (age 0 to 28 days) INCLUSION CRITERIA Infant 28 days of life Temperature 38 C (100.4 F) by any route/parental report EXCLUSION CRITERIA Infants with RSV Febrile Infant 28 days old Ill
More informationCare Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience
More informationGuidebook for ED and Inpatient Sepsis Order Set Initiatives 2018
Background The leadership of the Surviving Sepsis Campaign (SSC) believes, since its inception, that both the SSC Guidelines and the SSC performance improvement indicators (1) will evolve as new evidence
More informationSepsis Story At Intermountain Healthcare Intensive Medicine Clinical Program
Sepsis Story At Intermountain Healthcare 2004-2012 Intensive Medicine Clinical Program The International Surviving Sepsis Campaign Was Organized In 2002 During The ESICM International Meeting In Barcelona,
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationtowards early goal directed therapy
Paediatric Septic Shock- towards early goal directed therapy Elliot Long Paediatric Acute Care 2011 Conference Outline Emergency Department Rivers Protocol (EGDT) ACCM Sepsis Protocol Evidence Barriers
More informationCASE SCENARIO EXERCISE
påçííáëü=pìêîéáää~ååé=çñ=eé~äíüå~êé ^ëëçåá~íéç=fåñéåíáçå=mêçöê~ããé CASE SCENARIO EXERCISE CATHETER-ASSOCIATED URINARY TRACT INFECTION SURVEILLANCE SCOTTISH SURVEILLANCE OF HEALTHCARE ASSOCIATED INFECTION
More informationEvaluation of Vancomycin Continuous Infusion in Trauma Patients
OBJECTIVES Evaluation of Vancomycin Continuous Infusion in Trauma Patients Brittany D. Bissell, Pharm.D. PGY-2 Critical Care Pharmacy Resident Jackson Memorial Hospital Miami, Florida Evaluate the potential
More informationSepsi: nuove definizioni, approccio diagnostico e terapia
GIORNATA MONDIALE DELLA SEPSI DIAGNOSI E GESTIONE CLINICA DELLA SEPSI Giovedì, 13 settembre 2018 Sepsi: nuove definizioni, approccio diagnostico e terapia Nicola Petrosillo Società Italiana Terapia Antiinfettiva
More informationTailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018
Tailored Volume Resuscitation in the Critically Ill is Achievable Heath E Latham, MD Associate Professor Fellowship Program Director Pulmonary and Critical Care Objectives Describe the goal of resuscitation
More informationNoah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018
Postnatal Steroids Use for Bronchopulmonary Dysplasia in 2018 + = Noah Hillman M.D. IPOKRaTES Conference Guadalajaira, Mexico August 23, 2018 AAP Policy Statement - 2002 This statement is intended for
More informationIntroduction. Centers for Disease Control and Prevention (CDC),
When Prevention Fails: The Clinical and Economic Impact of Sepsis Introduction Healthcare-associated infections are one of the top 0 leading causes of death in the U.S. The US Centers for Disease Control
More informationRetrospective study; only patients w/lactate > 4. Initial Lactate: Did not address
References and Literature Grading Is Lactate Measurement in the Emergency epartment Valuable as a Predictor of Outcomes in Adult Patients with Sepsis? Reference Grade Rank omment Support for: Lokhandwala,
More informationFrank Sebat, MD - June 29, 2006
Types of Shock Hypovolemic Shock Low blood volume decreasing cardiac output. AN INTEGRATED SYSTEM OF CARE FOR PATIENTS AT RISK SHOCK TEAM and RAPID RESPONSE TEAM Septic or Distributive Shock Decrease in
More informationPediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee
Pediatric Septic Shock Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee Case 4 year old male with a history of gastroschesis repaired
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationSepsis Update: Focus on Early Recognition and Intervention. Disclosures
Sepsis Update: Focus on Early Recognition and Intervention Jessie Roske, MD October 2017 Disclosures I have no actual or potential conflict of interest in relation to this program/presentation. I will
More informationDisclosures. Objectives. Epidemiology. Enterovirus 68. Enterovirus species 9/24/2015. Enterovirus D68: Lessons Learned from the Frontline
Enterovirus D68: Lessons Learned from the Frontline Disclosures Jennifer Schuster, MD MSCI Children s Mercy Hospital Pediatric Infectious Diseases September 16, 2015 I have nothing to disclose I do not
More informationInternational Journal of Pediatrics and Neonatal Health
International Journal of Pediatrics and Neonatal Health Research Article ISSN 2572-4355 Reduction in Deaths due to Severe Pneumonia with all-inclusive Treatment Subhashchandra Daga *1, Bela Verma 2, Chhaya
More informationSevere Sepsis/ Septic Shock. Fereshte Sheybani, MD. Assistant Professor in Infectious Diseases
Severe Sepsis/ Septic Shock Fereshte Sheybani, MD. Assistant Professor in Infectious Diseases Sepsis is one of the oldest and most elusive syndromes in medicine. Hippocrates claimed that sepsis (σήψις)
More informationCEDR 2018 QCDR Measures for CMS 2018 MIPS Performance Year Reporting
ACEP19 Emergency Department Utilization of CT for Minor Blunt Head Trauma for Aged 18 Years and Older Percentage of visits for aged 18 years and older who presented with a minor blunt head trauma who had
More informationThe Usefulness of Sepsis Biomarkers. Dr Vineya Rai Department of Anesthesiology University of Malaya
The Usefulness of Sepsis Biomarkers Dr Vineya Rai Department of Anesthesiology University of Malaya 1 What is Sepsis? Whole Body Inflammatory State + Infection 2 Incidence and Burden of Sepsis in US In
More informationSepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
More informationVAP Are strict diagnostic criteria advisable?
VAP Are strict diagnostic criteria advisable? Javier Garau, MD, PhD 18th Infection and Sepsis Symposium, Porto, 27th February 2013 Limitations of current definitions Alternatives -Streamlined definition
More informationFLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL
FLUID RESUSCITATION AND MONITORING IN SEPSIS PROTOCOLIZED VS USUAL CARE DEEPA BANGALORE GOTUR MD, FCCP ASSISTANT PROFESSOR, WEILL CORNELL MEDICAL COLLEGE NOVEMBER 10 TH 2017 TEXAS SCCM SYMPOSIUM Disclosures
More informationTerapia della candidiasi addomaniale
Verona 16 marzo 2018 Terapia della candidiasi addomaniale Pierluigi Viale Infectious Disease Unit Teaching Hospital S. Orsola Malpighi Bologna INTRA ABDOMINAL CANDIDIASIS open questions a single definition
More information2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand
2016 Sepsis Update: Pearls, Pitfalls, and Core Measure Quicksand Jack Perkins, MD FACEP, FAAEM, FACP Assistant Professor of Emergency and Internal Medicine Virginia Tech Carilion School of Medicine Why
More informationSepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018
Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018 Objectives 1. To identify the symptom of severe sepsis and septic shock syndrome.
More information